OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the FDA Regulatory approval for interchangeability was supported by positive phase III data demonstrating compar
ROSSING,Namibia,March 10,2025--On Saturday morning,the 34th Rossing National Marathon Championship (Rossing Marathon) was grandly inaugurated in the coastal town of Swakopmund in Namibia,with a ceremo
SINGAPORE and NEW YORK,March 10,2025-- SPRIM Global Investments ("SGI"),a global investment firm specializing in clinical-stage life sciences and pharma services based in Singapore,and One
BEIJING,March 10,2025-- A news report fromchinadaily.com.cn： In 2024,China expanded its high-level opening-up and achieved fruitful results.
Join Our Event at the Pullman Jakarta Central Park on 23 March 2025 HONG KONG,March 10,2025-- Choosing the right university is a pivotal decision for many students,given the numerous options and the c
CHENGDU,China,March 10,2025--SichuanKelun-BiotechBiopharmaceuticalCo.,Ltd. (the"Company") announced that the Company\'s trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conj
